Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04567537 · ClinicalTrials.gov registry record · NA
Laser Treatment for the Improvement of Scars and Scleroderma
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04567537: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT04567537 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04567537, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
In this study, the investigators seek to evaluate the effects of a laser treatment on the redistribution/regeneration of collagen on the clinical, microscopic, and molecular profiles of hypertrophic scars and scleroderma.
Interventions
- DEVICE Laser Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-06-02 |
| Est. Completion | 2025-04-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04567537
The ClinicalTrials.gov registry entry for NCT04567537 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Laser Treatment is the first listed.
NCT04567537 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04567537 about?
NCT04567537 is a clinical study titled "Laser Treatment for the Improvement of Scars and Scleroderma". In this study, the investigators seek to evaluate the effects of a laser treatment on the redistribution/regeneration of collagen on the clinical, microscopic, and molecular profiles of hypertrophic scars and scleroderma.
What is the current status of trial NCT04567537?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2021-06-02. Estimated completion is 2025-04-10.
What interventions are being tested in trial NCT04567537?
The interventions under investigation include: Laser Treatment (DEVICE).
Who is sponsoring clinical trial NCT04567537?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.